177756-61-5Relevant articles and documents
Development of a practical route for the manufacture of N-[5-(3-lmidazol-1-yl-4-methanesulfonyl-phenyl)-4-methyl-thiazol-2-yl]acetamide
Hirt, Hans,Haenggi, Ruedi,Reyes, Jesus,Seeger-Weibel, Manuela,Gallou, Fabrice
, p. 111 - 115 (2012/12/31)
An efficient synthesis of a potent candidate in our respiratory program is described. The synthesis based on a key Darzens condensation-α,β- epoxide rearrangement circumvented the toxicity and safety issues encountered in the original synthesis route. Sub
GPCR AGONISTS
-
Page/Page column 20, (2010/11/25)
Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.
GPCR AGONISTS
-
Page/Page column 33-34, (2010/11/25)
Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.
2-Fluorobenzenesulfonyl compounds for the treatment of inflammation
-
, (2008/06/13)
Methods of treating cyclooxygenase-2 mediated disorders comprising administering to a subject a therapeutically effective amount of one or more 2-fluorobenzenesulfonyl compounds corresponding to Formula I: wherein A, R1, R2, and R3 are as described in the specification, and novel 2 fluorobenzenesulfonyl compounds within Formula I.